Is enalapril safe for a 12-year-old spayed female Shih Tz...

Hello. This is a common and important clinical scenario, and you're right to be cautious when initiating an ACE inhibitor in a patient with advanced azotemia.

Let's break down the safety and dosing considerations for your 12-year-old spayed female Shih Tzu with advanced CKD (Creatinine 3.5 mg/dL, BUN 80 mg/dL) and hypertension (160/95 mmHg).

Is Enalapril Safe?

Yes, enalapril, an ACE inhibitor, can be a safe and beneficial medication for a dog with CKD and hypertension, but it requires careful initiation and monitoring. The primary benefits of enalapril in this patient are:

Antihypertensive effect: Her current blood pressure of 160/95 mmHg is significant and warrants intervention to prevent target organ damage (retinal detachment, stroke, cardiac hypertrophy, further renal damage).

Reduction of proteinuria: While you haven't provided a UPC ratio, hypertension and advanced CKD often go hand-in-hand with proteinuria, which ACE inhibitors effectively reduce. Reducing proteinuria can help slow the progression of CKD.

Renoprotective effects: By modulating intraglomerular hemodynamics, ACE inhibitors can help preserve renal function over time, even in advanced stages.

However, the primary concern with initiating an ACE inhibitor in a patient with significant azotemia is the potential for an acute exacerbation of azotemia. ACE inhibitors cause efferent arteriolar vasodilation, which can reduce intraglomerular pressure and, in some cases, lead to a transient decrease in glomerular filtration rate (GFR). This effect is generally mild and often clinically insignificant in patients with mild to moderate CKD, but it becomes more pronounced and risky in advanced CKD where the kidneys are already significantly compromised.

Dose Adjustments and Monitoring

Given her creatinine of 3.5 mg/dL and BUN of 80 mg/dL, I would recommend starting with a very conservative dose of enalapril and implementing a strict monitoring protocol.

1. Initial Dosing:
My standard dose for enalapril is 0.5 mg/kg PO q24h. However, for this patient, I would recommend starting at half of the typical starting dose, or even a quarter dose, to minimize the risk of acute azotemia.

* Conservative Start: Consider starting at 0.25 mg/kg PO q24h. If her weight is very low, you might even consider 0.125 mg/kg PO q24h for a few days before increasing.

2. Hydration Status:
Ensure the patient is well-hydrated before starting enalapril. Dehydration can exacerbate the risk of acute azotemia when initiating an ACE inhibitor.

3. Critical Monitoring Timeline:
* Recheck Renal Values (BUN, Creatinine, Phosphorus, Potassium): This is paramount. Recheck these parameters within 3-7 days of starting enalapril or any dose increase.
* What to expect: A modest increase (up to 20-30%) in creatinine is often considered an acceptable, even expected, physiological response to the change in renal hemodynamics. This reflects the reduction in intraglomerular pressure.
* When to be concerned: If the creatinine increases by more than 30%, or if the patient develops clinical signs of worsening azotemia (lethargy, anorexia, vomiting), you should reduce the dose or discontinue enalapril and re-evaluate.
* Hyperkalemia: Monitor potassium closely, especially if she is also on a renal diet or receiving other medications that could affect potassium levels.
* Recheck Blood Pressure: Recheck her blood pressure within 3-7 days as well to assess the efficacy of the enalapril. The goal is to reduce the systolic pressure to below 160 mmHg, ideally below 150 mmHg, without causing hypotension.
* Clinical Signs: Closely monitor for any signs of lethargy, anorexia, vomiting, or weakness, which could indicate a significant drop in GFR or hypotension.

4. Long-term Management:
* Once stable on the initial dose and if renal values are acceptable, you can consider gradually increasing the enalapril dose (e.g., to 0.5 mg/kg q24h) until the blood pressure is controlled, always rechecking renal values and blood pressure after each adjustment.
* Dietary Management: Ensure she is on a prescription renal diet, which is crucial for managing CKD progression, hyperphosphatemia, and proteinuria.
* Adjunctive Antihypertensives: If enalapril alone is insufficient to control her blood pressure, amlodipine (a calcium channel blocker) is an excellent choice to add to the regimen. It works via a different mechanism and is very effective at lowering blood pressure in dogs.

Summary

Enalapril can be a valuable tool for your patient, but her advanced CKD necessitates a cautious approach. Start with a low dose (e.g., 0.25 mg/kg PO q24h), ensure adequate hydration, and perform crucial rechecks of renal values and blood pressure within 3-7 days. This methodical approach will allow you to maximize the benefits while minimizing the risks.

Confidence Level: High confidence – this is a standard approach to managing hypertension and CKD.